Apyx Medical Corp Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Apyx Medical Corp (APYX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-10
- Apyx Medical Corp valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.40M, a 67.44% decline from fiscal 2024.
- Apyx Medical Corp valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $4.30M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $1.40M 10-K · filed 2026-03-10 |
| 2024-12-31 | $4.30M 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |